)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
VolitionRX
VolitionRX (VNRX) investor relations material
VolitionRX Corporate Presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate Presentation summary8 Jan, 2026
Mission and business model
Aims to save lives and improve outcomes for people and animals globally, focusing on cancer and sepsis diagnostics.
Operates an asset-light, low-capex, low-opex model, leveraging commercial partnerships and out-licensing.
Monetizes intellectual property through upfront, milestone, and recurring revenue from licensing agreements.
Holds 71 patents with coverage up to 2044, supporting a strong IP position.
Team has hundreds of years of combined experience and a track record of successful licensing.
Product portfolio and technology
Offers a platform-agnostic, low-cost diagnostic technology adaptable to various workflows, including manual, automated, and point-of-care settings.
Product suite includes Nu.Q® Cancer, Nu.Q® NETs, Nu.Q® Vet, Capture Seq, and Nu.Q® Discover, targeting multi-billion dollar markets.
Nu.Q® Vet is available in the US, Europe, and Asia, with over 120,000 tests sold in 2024 and recommended for at-risk dogs.
Nu.Q® Cancer addresses all five blood test applications in lung cancer, with direct sales expected in France in 1H 2026.
Nu.Q® NETs is CE marked and under validation for over 20 clinical utilities, including sepsis and autoimmune diseases.
Commercialization and partnerships
Commercialization strategy centers on licensing and partnerships with companies that have broad reach and large installed bases.
Secured significant deals, including $10M upfront and $13M milestone payments from Antech, and partnerships with Fujifilm, IDEXX, and others.
Recent agreements include research and commercial options with Werfen, Hologic, Diagenode, and HCL.
In confidential licensing discussions with around 10 large diagnostic and liquid biopsy companies, with first deals signed in Q3 2025.
Anticipates adoption into routine clinical practice and national screening programs starting in 2026.
Human licensing deal progress and timeline
Nu.Q NETs EU sales ramp-up strategy
Nu.Q Cancer path to national screening adoption
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next VolitionRX earnings date
Q4 202527 Mar, 2026
VolitionRX
Next VolitionRX earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
VolitionRX Ltd is a multi-national epigenetics company that specializes in the development of blood tests through its proprietary Nucleosomics™ platform. This platform is designed to create simple, easy-to-use, and cost-effective blood tests aimed at diagnosing and monitoring a variety of life-altering diseases, including some cancers and diseases related to NETosis, such as sepsis and COVID-19. The company is headquartered in Henderson, Nevada, and its shares are listed on the NYSE American under the ticker symbol VNRX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage